Kyle Piskel sold $3.2M of Adaptive Biotechnologies (ADPT)

Executed Nov 28 2025, disclosed Dec 2 2025, 4 days later.

Value, as filed

$3.2M

162,820 sh × $19.50

Executed

Nov 28 2025

the trade date, as filed

Disclosed

Dec 2 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Kyle Piskel Chief Financial Officer profile →

Kyle Piskel (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $3.2M of ADPT (162,820 sh × $19.50, as filed), executed Nov 28 2025.

The name

ADPT

Adaptive Biotechnologies Corporation ADPT · Healthcare · 80 filings in 24 months ticker →

Healthcare · Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of v…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kyle Piskel in ADPT

ADPTSALE Adaptive Biotechnologies Corporation $246K
18,672 sh × $13.17
Exec Mar 11
Filed Mar 13 · 5:30 PM ET